The U.S. Food and Drug Administration (FDA) has cleared its first ever lab-grown meat product as safe for human consumption, the agency announced Wednesday. The product is a “slaughter-free” chicken, grown from cultured cells, which could be rolled out to the public in a matter of months.
Upside Foods is the company behind the cell-cultured chicken, which is grown in a process that the New York Times says is “often compared to brewing beer.” Animal cells are grown in controlled environments within stainless-steel tanks, creating a product that — should be — biologically identical to conventional meat.
So far, lab-grown meat has received regulatory approval only in Singapore, where a cultivated chicken product from Good Meat was approved in 2020.
“The world is experiencing a food revolution and the (FDA) is committed to supporting innovation in the food supply,” said FDA Commissioner Robert M. Califf and Susan Mayne, director of the FDA’s Center for Food Safety and Applied Nutrition in a statement.
“We are thrilled at FDA’s announcement,” said David Kay, Upside’s director of communications, in an email. “This historic step paves the way for our path to market.”
Demand for alternatives to farmed meat has grown alongside awareness of the high greenhouse gas emissions of raising livestock, not to mention the treatment of various animals raised in cages or other restricted environments strictly for food production.
Cultivated chicken was even served to attendees at this year’s COP27 climate conference in Egypt.
Still, critics question if people will be willing to eat meat that was made in a lab and whether it will be affordable for the everyday person.
— With files from Reuters
1:31
Where’s the beef? Israeli company developing lab-grown steak
© 2022 Global News, a division of Corus Entertainment Inc.